BECTON DICKINSON & CO·4

May 10, 3:16 PM ET

Hickey David 4

4 · BECTON DICKINSON & CO · Filed May 10, 2022

Insider Transaction Report

Form 4
Period: 2022-05-06
Hickey David
EVP & President, Life Sciences
Transactions
  • Sale

    Common Stock

    2022-05-06$256.00/sh475$121,6003,806 total
Footnotes (1)
  • [F1]Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person and and amounts previously deferred and reported on Table II.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES